Fred E. Cohen Insider Profile

4 Followers
Fred E. Cohen, Director at Genomic Health, holds 143.16K shares in CareDx (Ticker: CDNA), holds 49.45K shares in Intellia Therapeutics (Ticker: NTLA), holds 22.69K shares in Progyny (Ticker: PGNY).
tipranks
Fred E. Cohen

Fred E. Cohen
Genomic Health (GHDX)
Director

Ranked #83,592 out of 99,218 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-37.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$29M
77.60%
11.37%
3.10%
2.97%
4.97% Others
A breakdown of Fred E. Cohen's holdings

Insider Roles

Kyverna Therapeutics, Inc.
(KYTX)
Director, Ten Percent Owner
CareDx
(CDNA)
Director
BioCryst
(BCRX)
Director
Urogen Pharma
(URGN)
Director
+5 other positions
Roles that Fred E. Cohen holds in companies

Most Profitable Insider Trade

Stock:
BioCryst
(BCRX)
Rating:Informative Buy
Date:Jan 09, 2015 - Jan 09, 2016
Return:-30.50%
The most profitable trade made by Fred E. Cohen

Fred E. Cohen's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GHDX
Genomic Health
Nov 14, 2019
Uninformative Sell
$0.00
Intellia Therapeutics
Jun 14, 2024
Director
Uninformative Buy
$732.40K
Urogen Pharma
Jul 28, 2023
Director
Uninformative Buy
661.49K
$845.94K
Progyny
May 28, 2024
Director
Uninformative Buy
$340.39K
Kyverna Therapeutics, Inc.
Feb 14, 2024
Director, Ten Percent Owner
Uninformative Buy
$22.12M
BioCryst
Sep 20, 2017
Director
Uninformative Buy
231.65K
$882.36K
CareDx
Jun 18, 2024
Director
Uninformative Buy
$3.24M
FPRX
Five Prime Therapeutics
Jul 03, 2014
Uninformative Buy
$942.67K
Tandem Diabetes Care
Director
$0.00
Veracyte
Oct 20, 2020
Director
Uninformative Buy
76.00K
$343.10K
ROKA
Sorrento Tech Inc
$0.00
IQVIA Holdings
Director
$0.00
List of latest transactions for each holding click on a transaction to see Fred E. Cohen's performance on stock

Fred E. Cohen insider profile FAQ

What is the percentage of profitable transactions made by Fred E. Cohen?
The percentage of profitable transactions made by Fred E. Cohen is 0%.
    What is the average return per transaction made by Fred E. Cohen?
    The average return per transaction made by Fred E. Cohen is -37.80%.
      What stocks does Fred E. Cohen hold?
      Fred E. Cohen holds: GHDX, NTLA, URGN, PGNY, KYTX, BCRX, CDNA, FPRX, TNDM, VCYT, ROKA, IQV stocks.
        What was Fred E. Cohen’s latest transaction?
        Fred E. Cohen latest transaction was an Uninformative Buy of ―.
          What was Fred E. Cohen's most profitable transaction?
          Fred E. Cohen’s most profitable transaction was an Informative Buy of BCRX stock on January 9, 2015. The return on the trade was -30.50%.
            What is Fred E. Cohen's role in Genomic Health?
            Fred E. Cohen's role in Genomic Health is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.